← Back to Screener
Mereo BioPharma Group plc American Depositary Shares (MREO)
Price$0.34
Favorite Metrics
Price vs S&P 500 (26W)-91.57%
Price vs S&P 500 (4W)-11.07%
Market Capitalization$51.92M
All Metrics
Book Value / Share (Quarterly)$0.05
P/TBV (Annual)9.00x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.04
Price vs S&P 500 (YTD)-23.36%
EPS (TTM)$-0.05
10-Day Avg Trading Volume1.83M
EPS Excl Extra (TTM)$-0.05
EPS (Annual)$-0.05
ROI (Annual)-65.04%
Gross Margin (Annual)73.40%
Cash / Share (Quarterly)$0.05
ROA (Last FY)-56.62%
EBITD / Share (TTM)$-0.05
ROE (5Y Avg)-50.82%
Cash Flow / Share (Annual)$-0.04
P/B Ratio1.27x
P/B Ratio (Quarterly)1.44x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-8.46x
ROA (TTM)-72.88%
EV / EBITDA (TTM)0.11x
EPS Incl Extra (Annual)$-0.05
Current Ratio (Annual)5.40x
Quick Ratio (Quarterly)10.38x
3-Month Avg Trading Volume10.72M
52-Week Price Return-84.20%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.05
P/S Ratio (Annual)103.85x
Asset Turnover (Annual)0.15x
52-Week High$3.05
EPS Excl Extra (Annual)$-0.05
CapEx CAGR (5Y)91.99%
26-Week Price Return-82.83%
Quick Ratio (Annual)5.38x
13-Week Price Return-53.03%
Total Debt / Equity (Annual)0.09x
Current Ratio (Quarterly)10.46x
Enterprise Value$10.933
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-8375.60%
Cash / Share (Annual)$0.09
3-Month Return Std Dev72.45%
Net Income / Employee (TTM)$-1
ROE (Last FY)-70.94%
Net Interest Coverage (Annual)-1.79x
EPS Basic Excl Extra (Annual)$-0.05
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.05
ROI (TTM)-83.24%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.08
Price vs S&P 500 (52W)-119.29%
Year-to-Date Return-19.22%
5-Day Price Return5.19%
EPS Normalized (Annual)$-0.05
ROA (5Y Avg)-74.73%
Net Profit Margin (Annual)-8375.60%
Month-to-Date Return2.00%
Cash Flow / Share (TTM)$-4.46
EBITD / Share (Annual)$-0.05
Operating Margin (Annual)-8021.40%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-39.82%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.05
P/TBV (Quarterly)1.46x
P/B Ratio (Annual)8.91x
Book Value / Share (Annual)$0.08
Price vs S&P 500 (13W)-55.89%
Beta0.33x
Revenue / Share (TTM)$0.00
ROE (TTM)-83.24%
52-Week Low$0.20
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
MREOMereo BioPharma Group plc American Depositary Shares | — | — | — | — | $0.34 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Mereo BioPharma is a UK-based biopharmaceutical company developing treatments for rare genetic disorders. Its lead candidates are setrusumab for osteogenesis imperfecta and alvelestat for alpha-1 antitrypsin deficiency-related lung disease, both in late-stage clinical development.